Stockscreener 앱 받기
149.84
3.07%
-4.74
시장 영업 전:
149.90
0.06
+0.04%
전일 마감가:
$154.58
열려 있는:
$154.7
하루 거래량:
1.07M
Relative Volume:
0.69
시가총액:
$20.26B
수익:
$1.53B
순이익/손실:
$-214.69M
주가수익비율:
-85.14
EPS:
-1.76
순현금흐름:
$-43.68M
1주 성능:
-0.68%
1개월 성능:
-6.68%
6개월 성능:
+20.99%
1년 성능:
+66.49%
1일 변동 폭
$148.78
$154.70
1주일 범위
$146.35
$155.64
52주 변동 폭
$83.13
$183.00
Natera Inc Stock (NTRA) Company Profile
명칭
Natera Inc
전화
650-249-9090
주소
13011 MCCALLEN PASS, AUSTIN, CA
NTRA을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
NTRA
Natera Inc
|
149.84 | 20.26B | 1.53B | -214.69M | -43.68M | -1.76 |
|
TMO
Thermo Fisher Scientific Inc
|
513.67 | 196.14B | 42.88B | 6.34B | 7.27B | 16.53 |
|
DHR
Danaher Corp
|
210.41 | 152.09B | 23.88B | 3.90B | 5.30B | 5.28 |
|
IDXX
Idexx Laboratories Inc
|
417.71 | 34.45B | 3.90B | 887.87M | 798.08M | 10.67 |
|
A
Agilent Technologies Inc
|
119.90 | 34.20B | 6.53B | 1.26B | 1.31B | 4.35 |
|
IQV
Iqvia Holdings Inc
|
180.02 | 32.81B | 15.41B | 1.37B | 2.11B | 7.50 |
Natera Inc Stock (NTRA) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-03-13 | 개시 | RBC Capital Mkts | Outperform |
| 2025-01-23 | 개시 | Barclays | Overweight |
| 2024-06-03 | 재개 | Jefferies | Buy |
| 2024-04-08 | 재개 | Craig Hallum | Buy |
| 2024-02-20 | 다운그레이드 | Raymond James | Strong Buy → Outperform |
| 2023-12-29 | 재확인 | BTIG Research | Buy |
| 2023-12-14 | 개시 | Guggenheim | Buy |
| 2023-12-13 | 개시 | Wolfe Research | Outperform |
| 2023-11-13 | 업그레이드 | Raymond James | Outperform → Strong Buy |
| 2023-09-28 | 개시 | Bernstein | Mkt Perform |
| 2023-07-05 | 재개 | JP Morgan | Overweight |
| 2023-05-05 | 개시 | UBS | Buy |
| 2023-01-18 | 업그레이드 | Raymond James | Mkt Perform → Outperform |
| 2022-08-25 | 개시 | Credit Suisse | Outperform |
| 2022-04-25 | 개시 | Stephens | Overweight |
| 2022-03-08 | 개시 | Goldman | Buy |
| 2022-01-06 | 재개 | Piper Sandler | Overweight |
| 2021-10-15 | 재개 | Cowen | Outperform |
| 2021-06-15 | 개시 | Raymond James | Mkt Perform |
| 2021-05-25 | 개시 | Wells Fargo | Overweight |
| 2021-01-28 | 개시 | Truist | Buy |
| 2020-10-08 | 개시 | BTIG Research | Buy |
| 2020-09-28 | 개시 | Morgan Stanley | Overweight |
| 2020-09-17 | 개시 | SVB Leerink | Outperform |
| 2020-06-10 | 재개 | Piper Sandler | Overweight |
| 2020-05-07 | 업그레이드 | JP Morgan | Neutral → Overweight |
| 2018-10-05 | 개시 | JP Morgan | Neutral |
| 2018-07-05 | 재확인 | Piper Jaffray | Overweight |
| 2017-08-07 | 재확인 | Morgan Stanley | Overweight |
| 2016-11-10 | 재확인 | The Benchmark Company | Buy |
| 2016-05-23 | 재확인 | The Benchmark Company | Buy |
| 2016-05-11 | 재확인 | The Benchmark Company | Buy |
| 2016-04-19 | 개시 | The Benchmark Company | Buy |
| 2015-09-28 | 업그레이드 | Wedbush | Neutral → Outperform |
| 2015-08-14 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
| 2015-08-04 | 개시 | Robert W. Baird | Outperform |
| 2015-07-27 | 개시 | Morgan Stanley | Equal-Weight |
| 2015-07-27 | 개시 | Piper Jaffray | Overweight |
| 2015-07-27 | 개시 | Wedbush | Neutral |
모두보기
Natera Inc 주식(NTRA)의 최신 뉴스
DEFINE-HT Selected for Late-Breaking Oral Presentation at ISHLT Annual Meeting - Yahoo Finance
Natera’s Busy 2025 Continues - The Healthcare Technology Report.
(PDF) Understanding the clinical genetics of kidney stone disease using the Natera Renasight panel - ResearchGate
Is Natera, Inc. (NTRA) the Best Diagnostics Stock to Invest in Right Now? - Insider Monkey
Natera Investors Get Class Status in Prenatal Screening Lawsuit - Bloomberg Law
Guardant Health gains amid $292.5M verdict against Natera over false advertising claims (update) - MSN
Natera CFO Michael Burkes sells $115,661 in company stock By Investing.com - Investing.com South Africa
Here’s What Lifted Natera (NTRA) in Q4 and 2024 - MSN
Natera’s president John Fesko sells $116,099 in stock By Investing.com - Investing.com Canada
Natera (NASDAQ:NTRA) Q4 Earnings: Leading The Immuno-Oncology Pack - Yahoo Finance
Natera’s chief legal officer sells $135,521 in stock By Investing.com - Investing.com Canada
Natera president sells $149,835 in stock By Investing.com - Investing.com Canada
Natera’s executive chairman sells $164,583 in stock By Investing.com - Investing.com Canada
Natera CEO Chapman sells $978,677 in company stock By Investing.com - Investing.com South Africa
Natera co-founder Sheena Jonathan sells $856,410 in stock By Investing.com - Investing.com South Africa
Natera president sells $149,835 in stock - Investing.com India
Natera’s chief legal officer sells $135,521 in stock - Investing.com India
Natera Executives and Directors Sell Shares to Cover Tax Obligations - TradingView
Natera CFO Michael Burkes sells $115,661 in company stock - Investing.com
Natera CEO Chapman sells $978,677 in company stock - Investing.com
Natera’s president John Fesko sells $116,099 in stock - Investing.com
Natera co-founder Sheena Jonathan sells $856,410 in stock - Investing.com India
Natera’s executive chairman sells $164,583 in stock - Investing.com India
Is Natera (NTRA) the Best Biotech Stock According to Billionaires? - Yahoo Finance
Judge Connolly (D. Del.) Overturns $96 Million Molecular Diagnostics Jury Verdict, Finds Patents Invalid Under § 112 - JD Supra
Is Natera, Inc. (NTRA) a Best Biotech Stock According to Billionaires? - Insider Monkey
Natera: Strong Growth Trajectory Despite Stretched Valuation Metrics (NASDAQ:NTRA) - Seeking Alpha
Natera Inc.: Strong Execution in Revenue Per Test Powering Our Optimism! - Smartkarma
Natera: Solid Execution, Pricey Stock (NASDAQ:NTRA) - Seeking Alpha
Natera: Growth Looks Unstoppable, Positive EPS Just A Matter Of Time - Seeking Alpha
Natera Inc (NTRA) Stock Price Up 4.01% on Mar 17 - GuruFocus.com
Natera initiated with an Outperform at RBC Capital - MSN
Natera Sees Unusually Large Options Volume (NASDAQ:NTRA) - Defense World
ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Natera, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action – NTRA - Business Wire
RBC Capital initiates Exact Sciences with Sector Perform, Natera with Outperform - MSN
INVESTOR DEADLINE: Natera, Inc. Investors with Substantial Losses Have Opportunity to Lead Natera Class Action Lawsuit – NTRA - Business Wire
Natera director Marcus Gail Boxer sells $590,773 in stock By Investing.com - Investing.com South Africa
Natera executive chairman sells $7.39 million in stock By Investing.com - Investing.com Canada
Natera director Marcus Gail Boxer sells $590,773 in stock - Investing.com India
Natera executive chairman sells $7.39 million in stock - Investing.com
Natera And 2 Other Stocks That May Be Trading Below Their Estimated Value - Simply Wall St
Natera, Inc. (NASDAQ:NTRA) Given Consensus Recommendation of “Buy” by Brokerages - Defense World
RBC Capital Initiates Coverage of Natera (NTRA) with Outperform Recommendation - Nasdaq
Natera (NasdaqGS:NTRA) Welcomes Former National Cancer Institute Director Back to Board - Simply Wall St
Natera Inc (NTRA) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Natera Inc 주식 (NTRA) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Brophy Michael Burkes | CHIEF FINANCIAL OFFICER |
Mar 17 '25 |
Sale |
146.04 |
792 |
115,661 |
71,869 |
| Sheena Jonathan | CO-FOUNDER |
Mar 18 '25 |
Sale |
145.65 |
3,000 |
436,952 |
41,782 |
| Sheena Jonathan | CO-FOUNDER |
Mar 18 '25 |
Sale |
145.57 |
2,700 |
393,027 |
258,319 |
| Sheena Jonathan | CO-FOUNDER |
Mar 17 '25 |
Sale |
146.03 |
181 |
26,431 |
261,019 |
| Rabinowitz Matthew | EXECUTIVE CHAIRMAN |
Mar 17 '25 |
Sale |
146.04 |
1,127 |
164,584 |
2,364,288 |
| RABINOWITZ DANIEL | SEC. AND CHIEF LEGAL OFFICER |
Mar 17 '25 |
Sale |
146.04 |
928 |
135,521 |
224,185 |
| Moshkevich Solomon | PRESIDENT, CLINICALDIAGNOSTICS |
Mar 17 '25 |
Sale |
146.04 |
1,026 |
149,836 |
144,782 |
| Fesko John | PRESIDENT, CHIEF BUS. OFFICER |
Mar 17 '25 |
Sale |
146.04 |
795 |
116,099 |
157,289 |
0.47%
0.58%
자본화:
|
볼륨(24시간):